Barinthus Biotherapeutics plc American Depositary Shares (BRNS)
PHARMACEUTICAL PREPARATIONS
- Headquarters
- United States
- Employees
- 14
- Market Cap
- $23M
About Barinthus Biotherapeutics plc American Depositary Shares
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapeutic drug candidates for treating autoimmune and inflammatory diseases. The company is prioritizing the development of its proprietary SNAP-TI platform, designed to promote immune tolerance, with its lead candidate VTP-1000 targeting celiac disease. It is also developing VTP-300 for chronic hepatitis B using viral vector platform technologies, aimed at inducing disease-specific immune responses.
SentiSense also tracks daily options readings for Barinthus Biotherapeutics plc American Depositary Shares: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Barinthus Biotherapeutics plc American Depositary Shares stock analysis, sentiment tracking, and market intelligence on SentiSense.